Acceleron Pharma Website Awarded "Pharmaceutical Industry Standard of Excellence" by the Web Marketing Association.CAMBRIDGE, Mass. -- Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, announced that the Web Marketing Association ("WMA (Windows Media Audio) An audio compression method from Microsoft. Known originally as MSAudio, this proprietary format competes with the MP3 and AAC methods. WMA encodes rapidly and is known to be especially effective at low bit rates. ") awarded a "Pharmaceutical Industry Standard of Excellence" WebAward for 2007 to the Company. Acceleron's website was created to accurately inform all key target audiences about the Company's R&D strategy, product pipeline and corporate vision. The website was designed, developed, and launched by Embarc, Inc., an Interactive Marketing Agency based in Newton Upper Falls, Massachusetts Newton Upper Falls is a village of Newton, Massachusetts, in the United States. The area borders Needham, Massachusetts. Newton Upper Falls is home to the famous Hemlock Gorge and Echo Bridge, a large aqueduct turned pedestrian walkway over the Charles River. . WMA, an organization devoted to establishing high standards for Internet marketing See Internet advertising. and corporate Web development, annually recognizes the individual and team achievement of Web professionals who create and maintain outstanding corporate websites. More than 2,400 sites from 40 countries were adjudicated in 96 industry categories during this year's competition. Entries were judged on design, copy writing, innovation, content, interactivity, navigation, and use of technology. About Acceleron Pharma Acceleron is a privately held biopharmaceutical company committed to discover, develop, manufacture and commercialize novel biotherapeutics that modulate the growth of bone, muscle, fat and the vasculature vasculature /vas·cu·la·ture/ (vas´ku-lah-chur) 1. circulatory system. 2. any part of the circulatory system. vas·cu·la·ture n. to treat musculoskeletal musculoskeletal /mus·cu·lo·skel·e·tal/ (-skel´e-t'l) pertaining to or comprising the skeleton and muscles. mus·cu·lo·skel·e·tal adj. Relating to or involving the muscles and the skeleton. , metabolic and cancer-related diseases. Acceleron's scientific approach takes advantage of its unique insight into the regenerative powers of two protein families: the Growth and Differentiation Factors (GDFs) and Bone Morphogenetic Proteins (BMPs). ACE-011, a novel bone forming agent, is the company's lead program, and is being developed to reverse bone loss in diseases such as cancer-related bone loss. In addition, the company is advancing through preclinical development product candidates that increase muscle mass, control angiogenesis angiogenesis /an·gio·gen·e·sis/ (-jen´e-sis) vasculogenesis; development of blood vessels either in the embryo or in the form of neovascularization or revascularization. an·gi·o·gen·e·sis n. and inhibit fat accumulation. Acceleron utilizes proven biotherapeutic technologies and capitalizes on the company's internal GMP GMP (guanosine monophosphate): see guanine. manufacturing capability to rapidly and efficiently advance its therapeutic programs. The investors in Acceleron are Advanced Technology Ventures, Flagship Ventures, OrbiMed Advisors, Polaris Ventures, Sutter Hill Ventures and Venrock. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion